Emcure Pharmaceuticals Limited (NSE:EMCURE)

Emcure Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Emcure Pharmaceuticals had annual revenue of 92.16B INR with 16.72% growth. Emcure Pharmaceuticals had revenue of 24.74B in the quarter ending March 31, 2026, with 16.89% growth.

• Revenue: 92.16B
• Revenue Growth: +16.72%
• P/S Ratio: 3.38
• Revenue / Employee: 13.69M
• Employees: 6,731
• Market Cap: 311.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	92.16B	13.20B	16.72%
Mar 31, 2025	78.96B	12.38B	18.59%
Mar 31, 2024	66.58B	6.72B	11.23%
Mar 31, 2023	59.86B	1.30B	2.23%
Mar 31, 2022	58.55B	8.22B	16.33%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 11, 2026

Data Sources Report a data error